Sector Update: Health Care Stocks Advance in Afternoon Trading

MT NewswiresDec 18 13:49 ET

KalVista Pharmaceuticals' Sebetralstat Poised to Disrupt Acute HAE Market With Oral Advantage, BofA Says

MT NewswiresDec 18 10:54 ET

This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

BenzingaDec 18 10:03 ET

KalVista Wins New Buy at BofA on Potential of Lead Candidate

Seeking AlphaDec 18 09:52 ET

BofA Securities Initiates KalVista Pharmaceuticals(KALV.US) With Buy Rating, Announces Target Price $22

Moomoo NewsDec 18 07:34 ET · Ratings

Express News | B of A Securities Initiates Coverage On KalVista Pharma With Buy Rating, Announces Price Target of $22

BenzingaDec 18 07:13 ET